ECP
LUXA

Empyrean Capital Partners’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Empyrean Capital Partners’s Portfolio LUXA Stock Details LUXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,000,649
Closed -$30.1M – 132
2022
Q3 		$30.1M Hold
3,000,649
– – 0.93% 32
2022
Q2 		$29.7M Hold
3,000,649
– – 0.94% 36
2022
Q1 		$29.6M Hold
3,000,649
– – 0.65% 49
2021
Q4 		$29.4M Buy
3,000,649
+1,000,000
+50% +$9.85M 0.78% 39
2021
Q3 		$19.6M Hold
2,000,649
– – 0.44% 65
2021
Q2 		$19.8M Buy
2,000,649
+200,000
+11% +$2.01M 0.45% 66
2021
Q1 		$18.5M Buy
+1,800,649
New +$20M 0.53% 54

Empyrean Capital Partners's LUXA Position: Q4 2022 in Review

Empyrean Capital Partners sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 3,000,649 shares — an estimated $30.1M sold.

Empyrean Capital Partners first reported a position in LUXA in Q1 2021 and held it in 7 quarters. The position peaked at $30.1M in Q3 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

  • Empyrean Capital Partners reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Empyrean Capital Partners sold 3,000,649 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $30.1M.
  • Empyrean Capital Partners first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 7 quarters.
  • Empyrean Capital Partners's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $30.1M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Empyrean Capital Partners's 13F filing for Q4 2022, filed 14 Feb 2023.